Mupirocin, often known by the brand name Bactroban, is a topical antibiotic prescribed to treat bacterial skin infections, such as impetigo and infections caused by Staphylococcus aureus (including MRSA) and Streptococcus pyogenes. While highly effective, there are specific circumstances and conditions where its use is not recommended or requires caution.
Absolute Contraindication: Known Hypersensitivity
The primary reason to avoid mupirocin is a known allergy or hypersensitivity to mupirocin or any of its ingredients, such as polyethylene glycol (PEG) found in the ointment. Allergic reactions can range from localized skin irritation to severe systemic reactions. If an allergic reaction occurs, discontinue use and seek medical help.
Critical Warnings and Precautions
Use on Large Wounds and in Patients with Kidney Disease
Mupirocin ointment contains polyethylene glycol (PEG), which can be absorbed through open wounds and is excreted by the kidneys. In patients with moderate to severe renal impairment, applying the ointment on large, open wounds or extensive burns can lead to toxic levels of PEG, potentially causing or worsening kidney damage. Therefore, mupirocin ointment should not be used in situations with potential for significant PEG absorption, especially with renal impairment.
Application on Mucous Membranes and Eyes
Mupirocin ointment and cream are for external use on the skin only and should not be applied to mucosal surfaces like the eyes, inside the nose, or mouth. Accidental eye contact should be followed by thorough rinsing with water. A specific nasal formulation is available for intranasal use.
Risk of Overgrowth and Antibiotic Resistance
Prolonged antibiotic use, including topical mupirocin, can disrupt the skin's microbial balance, potentially leading to overgrowth of non-susceptible organisms like fungi. Extended use can also contribute to antibiotic resistance. If the infection doesn't improve within 3 to 5 days, a healthcare provider should re-evaluate treatment.
Formulation | Prohibited Areas of Use | Key Considerations |
---|---|---|
Mupirocin Ointment/Cream | Eyes, inside the nose, mouth, other mucous membranes | Ointment contains PEG; avoid on large open wounds/burns in patients with kidney problems. |
Mupirocin Nasal Ointment | Eyes, on the skin (for skin infections) | For nasal MRSA eradication only. |
Special Populations
- Pregnancy and Breastfeeding: Data is limited, but systemic absorption is minimal. Risk to a nursing infant is considered low, but if applied to the breast/nipple, wash thoroughly before feeding.
- Pediatrics: Safety is not established for cream in children under 3 months and ointment under 2 months.
- IV Sites: Avoid use on skin near IV cannulae or central IV sites due to increased risk of fungal infections and resistance.
Conclusion
Mupirocin is effective for bacterial skin infections, but its use requires careful consideration of contraindications and warnings. The main reasons to avoid mupirocin are a known allergy, use on large open wounds in individuals with kidney issues, and application to the eyes or mucous membranes. Limiting use to the prescribed duration helps prevent fungal overgrowth and antibiotic resistance. Always consult a healthcare provider to ensure mupirocin is appropriate and safe for your condition.
For more detailed information, consult the official patient information leaflet provided by the U.S. Food and Drug Administration. Link